相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HOMA-IR and QUICKI: decide on a general standard instead of making further comparisons
Sophia M. Rossner et al.
ACTA PAEDIATRICA (2010)
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
Bernard Zinman et al.
LANCET (2010)
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
The economic consequences of diabetes and cardiovascular disease in the United States
Miguel A. Ariza et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2010)
Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus A Systematic Review With Meta-analysis
Rachel Huxley et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Effects of Thiazolidinediones Beyond Glycaemic Control
Rigas G. Kalaitzidis et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: A post-hoc analysis of the BIGPRO1 trial
A. Fontbonne et al.
DIABETES & METABOLISM (2009)
Alcohol as a Risk Factor for Type 2 Diabetes A systematic review and meta-analysis
Dolly O. Baliunas et al.
DIABETES CARE (2009)
Impact of Natural Disaster on Diabetes Exacerbation of disparities and long-term consequences
Vivian A. Fonseca et al.
DIABETES CARE (2009)
Metformin - the gold standard in type 2 diabetes: what does the evidence tell us?
E. Bosi
DIABETES OBESITY & METABOLISM (2009)
Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors
Manfredi Rizzo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Actos Now for the prevention of diabetes (ACT NOW) study
Ralph A. DeFronzo et al.
BMC ENDOCRINE DISORDERS (2009)
Prevention of diabetes and cardiovascular' disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
Robert M. Califf et al.
AMERICAN HEART JOURNAL (2008)
Adjustable gastric banding and conventional therapy for type 2 diabetes - A randomized controlled trial
John B. Dixon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The prevention of type 2 diabetes
Jill P. Crandall et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose
Kristina M. Utzschneider et al.
DIABETES CARE (2008)
Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance
Julio Rosenstock et al.
DIABETES CARE (2008)
Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention:: follow-up of the Finnish Diabetes Prevention Study
Jaana Lindstrom et al.
LANCET (2006)
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
H. C. Gerstein et al.
LANCET (2006)
Effect of weight loss with lifestyle intervention on risk of diabetes
Richard F. Hamman et al.
DIABETES CARE (2006)
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function
A. Mari et al.
DIABETOLOGIA (2006)
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients
A Tenenbaum et al.
EUROPEAN HEART JOURNAL (2005)
Limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation
F Brandou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
Alexander Tenenbaum et al.
CARDIOVASCULAR DIABETOLOGY (2005)
Laparoscopic adjustable gastric banding induces prolonged satiety: A randomized blind crossover study
AFR Dixon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism
F Rubino et al.
ANNALS OF SURGERY (2004)
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
L Sjöström et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system
AJ Scheen
DRUGS (2004)
Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance
RJ Durbin
DIABETES OBESITY & METABOLISM (2004)
XENical in the prevention of diabetes in obese subjects (XENDOS) study
JS Torgerson et al.
DIABETES CARE (2004)
Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease
A Tenenbaum et al.
CIRCULATION (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease
SI McFarlane et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
AH Mokdad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women
TA Buchanan et al.
DIABETES (2002)
Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
JL Chiasson et al.
LANCET (2002)
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
LH Lindholm et al.
LANCET (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Ramipril and the development of diabetes
S Yusuf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
SB Heymsfield et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
